The NaBu Effect on Menstruation in Women

Description

The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.

Conditions

Menstrual Symptoms

Talk to us

Study Overview

On this page

Study Details

Study overview

The purpose of this study is to evaluate the effect of once-daily Sodium butyrate (NaBu) on menstrual symptoms in women. The investigators posit that the use of NaBu will reduce menstrual symptoms after taking NaBu for 12 weeks.

The Effect of Sodium Butyrate on Menstrual Symptoms in Women

The NaBu Effect on Menstruation in Women

Condition
Menstrual Symptoms
Intervention / Treatment

-

Contacts and Locations

Chicago

Northwestern University - Northwestern Medicine, Lavin Family Pavilion, Chicago, Illinois, United States, 60611

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * 18 years or older.
  • * Menstruating regularly or irregularly
  • * Experiencing menstrual symptoms with an average baseline symptom score of at least 3 on a scale of 0 to 10 for at least one symptom during the initial pre-study rating period.
  • * Pregnant or breastfeeding patient, attempting or anticipating pregnancy.
  • * Patient with a history of bloating or a sensitive gut (food intolerance) who needs lower fiber levels.
  • * Patients with known lactose intolerance, other fermentable oligo-, di-, and mono-saccharides, and polyols (FODMAP) intolerances, or small intestinal bacterial overgrowth (SIBO).
  • * Patients who would require taking daily antacids for the duration of the study.
  • * Patients with known or suspected chronic hypertension.
  • * Post-menopausal patients

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Magdy Milad, MD,

Magdy P Milad, MD MS, PRINCIPAL_INVESTIGATOR, Northwestern Medicine

Study Record Dates

2025-10